🔗 Share this article

A shadow market for unlicensed weight-loss drugs is being driven by social media fitness personalities and vendors on messaging platforms, according to new investigations.

Investigational Treatment Acquiring Popularity Online

The experimental drug, which is still in research studies, is being promoted by online personalities for its supposed fat-burning properties. Viewers are urged to message these profiles directly for source information, while also obtaining promotional offers.

Thriving Trade on Social Networks

Additionally, a flourishing trade exists on Telegram, where groups with numerous of participants share “before and after” photos, injection guides and claims of rapid British shipping. Sellers promote the drug there before directing buyers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and glucagon. Early trials indicate it could help patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Medical Experts Voice Concerns

However, doctors and pharmacists have cautions that the distribution of what remains an unapproved drug in the UK is worrisome and could result in users administering products of unknown origin.

Some experts said the popularity for retatrutide could be linked to the rising cost of approved weight loss products such as Mounjaro.

Legal Status and Enforcement

Selling retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unapproved medication that cannot be marketed or distributed for personal consumption under the British medical regulations.

Several content creators attempt to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still violate medicines, advertising, and consumer laws, risking penalties, legal action or imprisonment.

Service Reaction and Material Removal

Based on the social media company, the platform has taken down problematic material and banned associated hashtags and search suggestions. The company said it was committed to keeping the service safe and allocating resources in enhancing enforcement strategies.

Online Trading Operations

Research also found communities with up to 9,000 members marketing retatrutide using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly displays channels with numerous of members, populated with photos of weight loss, positive reviews and detailed guides for mixing or injecting at home.

After moments of entering one group, a seller shared contact information, where most transactions occur. The vendor sent an instruction manual and promised shipping within 48 hours. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a image of a alleged testing documentation. None asked about weight, medical conditions or previous experience.

Item Information and Pricing

Inside these communities, messages display black plastic parcels with Royal Mail stickers, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with sterile water, or pre-filled pens usually priced at 160 pounds for 20 milligrams. When questioned how much time a pen should last, sellers give conflicting answers varying between a several days to “depends on your body”.

Service Oversight and Safety Measures

A spokesperson for the messaging service stated it actively moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are injecting materials they cannot confirm. Although the science behind this drug is sound, these online products may not include what they claim,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the surge in interest to recent price rises for authorized weight-loss medications such as Mounjaro. “With prices increasing, individuals are turning to social media. But fake injections are highly dangerous. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she said.

Her staff has already seen individuals harmed by self-injection from unconfirmed sources. “We understand the frustration, but purchasing from Telegram or WhatsApp is taking chances with your well-being,” stated the doctor. “These materials could be impure or incorrectly dosed.”

Producer Position

A representative from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been reviewed or approved by any regulatory agency globally. “Consequently at this point no one can market [it] for human use,” they explained, noting that any item “falsely representing itself as a Lilly experimental substance not yet authorized … may expose users to possibly significant medical dangers”.